Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

9940.   Casey GJ, Ginny M, Uranoli M, Mueller I, Reeder JC, Genton B, Cowman AF. Molecular analysis of Plasmodium falciparum from drug treatment failure patients in Papua New Guinea. Am J Trop Med Hyg. 2004 Mar;70(3):251-5.

9941.   Casey JL, Coley AM, Anders RF, Murphy VJ, Humberstone KS, Thomas AW, Foley M.  Antibodies to malaria peptide mimics inhibit Plasmodium falciparum invasion of erythrocytes. Infect Immun. 2004 Feb;72(2):1126-34.

9942.   Farcas GA, Zhong KJ, Mazzulli T, Kain KC. Evaluation of the RealArt Malaria LC real-time PCR assay for malaria diagnosis. J Clin Microbiol. 2004 Feb;42(2):636-8.

9943.   Haddad D, Bilcikova E, Witney AA, Carlton JM, White CE, Blair PL, Chattopadhyay R, Russell J, Abot E, Charoenvit Y, Aguiar JC, Carucci DJ, Weiss WR. Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome. Infect Immun. 2004 Mar;72(3):1594-602.

9944.   Patel DN, Pradeep P, Surti MM, Agarwal SB. Clinical manifestations of complicated malaria. J Indian Acad clin med 2003; 4(4): 323-31.

9945.   Perandin F, Manca N, Calderaro A, Piccolo G, Galati L, Ricci L, Medici MC, Arcangeletti MC, Snounou G, Dettori G, Chezzi C. Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for routine clinical diagnosis. J Clin Microbiol. 2004 Mar;42(3):1214-9.

9946.   Ravindran R, Anam K, Bairagi BC, Saha B, Pramanik N, Guha SK, Goswami RP, Banerjee D, Ali N. Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy. Infect Immun. 2004 Feb;72(2):863-70.

9947.   Scopel KK, Fontes CJ, Nunes AC, Horta MF, Braga EM. High prevalence of Plamodium malariae infections in a Brazilian Amazon endemic area (Apiacas-Mato Grosso State) as detected by polymerase chain reaction. Acta Trop. 2004 Mar;90(1):61-4.

9948.   Shehata N, Kohli M, Detsky A. The cost-effectiveness of screening blood donors for malaria by PCR. Transfusion. 2004 Feb;44(2):217-28.

9949.   Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JG, Fosiko NG, Lewallen S, Liomba NG, Molyneux ME. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med. 2004 Feb;10(2):143-5.


9950.   Afrane YA, Klinkenberg E, Drechsel P, Owusu-Daaku K, Garms R, Kruppa T. Does irrigated urban agriculture influence the transmission of malaria in the city of Kumasi, Ghana? Acta Trop. 2004 Jan;89(2):125-34.

9951.   Basco LK, Tahar R, Escalante A. Molecular epidemiology of malaria in Cameroon. XVIII. Polymorphisms of the Plasmodium falciparum merozoite surface antigen-2 gene in isolates from symptomatic patients. Am J Trop Med Hyg. 2004 Mar;70(3):238-44.

9952.   Beeson JG, Brown GV. Plasmodium falciparum-infected erythrocytes demonstrate dual specificity for adhesion to hyaluronic acid and chondroitin sulfate A and have distinct adhesive properties. J Infect Dis. 2004 Jan 15;189(2):169-79.

9953.   Blandin S, Shiao SH, Moita LF, Janse CJ, Waters AP, Kafatos FC, Levashina EA. Complement-like protein TEP1 is a determinant of vectorial capacity in the malaria vector Anopheles gambiae. Cell. 2004 Mar 5;116(5):661-70.

9954.   Chaiyaroj SC, Rutta AS, Muenthaisong K, Watkins P, Na Ubol M, Looareesuwan S. Reduced levels of transforming growth factor-beta1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria. Acta Trop. 2004 Feb;89(3):319-27.

9955.   Diatta AM, Marrama L, Tall A, Trape JF, Dieye A, Garraud O, Mercereau-Puijalon O, Perraut R. Relationship of binding of immunoglobulin G to Plasmodium falciparum-infected erythrocytes with parasite endemicity and antibody responses to conserved antigen in immune individuals. Clin Diagn Lab Immunol. 2004 Jan;11(1):6-11.

9956.   Dondorp AM, Pongponratn E, White NJ. Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Trop. 2004 Feb;89(3):309-17. Review.

9957.   Kordai Sowa MP, Sharling L, Humphreys G, Cavanagh DR, Gregory WF, Fenn K, Creasey AM, Arnot DE. High throughput immuno-screening of cDNA expression libraries produced by in vitro recombination; exploring the Plasmodium falciparum proteome. Mol Biochem Parasitol. 2004 Feb;133(2):267-74.

9958.   Li X, Chen H, Oo TH, Daly TM, Bergman LW, Liu SC, Chishti AH, Oh SS. A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3. J Biol Chem. 2004 Feb 13;279(7):5765-71.

9959.   Ohas EA, Adams JH, Waitumbi JN, Orago AS, Barbosa A, Lanar DE, Stoute JA.  Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western Kenya. Infect Immun. 2004 Feb;72(2):735-41.

9960.   Okech BA, Corran PH, Todd J, Joynson-Hicks A, Uthaipibull C, Egwang TG, Holder AA, Riley EM. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect Immun. 2004 Mar;72(3):1557-67.

9961.   Purdy E, Perry E, Gorlin J, Jensen K. Transfusion-transmitted malaria: unpreventable by current donor exclusion guidelines? Transfusion. 2004 Mar;44(3):464.

9962.   Wassmer SC, Lepolard C, Traore B, Pouvelle B, Gysin J, Grau GE. Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to activated endothelial cells. J Infect Dis. 2004 Jan 15;189(2):180-9.

9963.   Winter G, Chen Q, Wahlgren M. Meeting report: the molecular background of severe and complicated malaria. Mol Biochem Parasitol. 2004 Mar;134(1):37-41.


9964.   McCarthy M. Preventing pregnancy malaria. Simple vaccines that stop parasites lodging in the placenta may save thousands of lives. Lancet. 2004 Jan 10;363(9403):132-3.

9965.   Moorthy VS, Good MF, Hill AV. Malaria vaccine developments. Lancet. 2004 Jan 10;363(9403):150-6. Review.

9966.   Nicholls H. Milking goats for malaria vaccine. Drug Discov Today. 2004 Mar 15;9(6):248.

9967.   Pinder M, Reece WH, Plebanski M, Akinwunmi P, Flanagan KL, Lee EA, Doherty T, Milligan P, Jaye A, Tornieporth N, Ballou R, McAdam KP, Cohen J, Hill AV.  Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia.Clin Exp Immunol. 2004 Feb;135(2):286-93.


9968.   Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N; International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004 Jan 3;363(9402):9-17.

9969.   Attaran A, Barnes KI, Curtis C, d'Alessandro U, Fanello CI, Galinski MR, Kokwaro G, Looareesuwan S, Makanga M, Mutabingwa TK, Talisuna A, Trape JF, Watkins WM.  WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet. 2004 Jan 17;363(9404):237-40. Review.

9970.   Barnes KI, Folb PI. Measuring resistance to malaria. S Afr Med J. 2004 Jan;94(1):36-7.

9971.   Bregani ER, Tien TV, Cabibbe M, Figini G, Manenti F. Holter monitoring in children with severe Plasmodium falciparum malaria during i.v. quinine treatment. J Trop Pediatr. 2004 Feb;50(1):61.

9972.   Brown G, Torresi J, Flint S. Delayed onset of malaria--implications for chemoprophylaxis. N Engl J Med. 2004 Jan 8;350(2):195-7; author reply 195-7.

9973.   Cayley WE Jr. Mefloquine for preventing malaria in nonimmune adult travelers. Am Fam Physician. 2004 Feb 1;69(3):521-2. Review.

9974.   Duffy PE, Mutabingwa TK. Drug combinations for malaria: time to ACT? Lancet. 2004 Jan 3;363(9402):3-4.

9975.   Greenwood B. Treating malaria in Africa. BMJ. 2004 Mar 6;328(7439):534-5.

9976.   Hemingway J, Craig A. Parasitology. New ways to control malaria. Science. 2004 Mar 26;303(5666):1984-5.

9977.   Hotez PJ, Remme JH, Buss P, Alleyne G, Morel C, Breman JG. Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project. Clin Infect Dis. 2004 Mar 15;38(6):871-8.

9978.   Krishnan A, Karnad DR, Limaye U, Siddharth W. Cerebral venous and dural sinus  thrombosis in severe falciparum malaria. J Infect. 2004 Jan;48(1):86-90.

9979.   Leslie T, Rab MA, Ahmadzai H, Durrani N, Fayaz M, Kolaczinski J, Rowland M.  Compliance with 14-day primaquine therapy for radical cure of vivax malaria—a randomized placebo-controlled trial comparing unsupervised with supervised  treatment. Trans R Soc Trop Med Hyg. 2004 Mar;98(3):168-73. 

9980.   McCarthy M. Preventing pregnancy malaria. Simple vaccines that stop parasites lodging in the placenta may save thousands of lives. Lancet. 2004 Jan 10;363(9403):132-3.

9981.   Myint HY, Tipmanee P, Nosten F, Day NP, Pukrittayakamee S, Looareesuwan S, White NJ. A systematic overview of published antimalarial drug trials. Trans R Soc Trop Med Hyg. 2004 Feb;98(2):73-81. Review. 

9982.   Pinder M, Reece WH, Plebanski M, Akinwunmi P, Flanagan KL, Lee EA, Doherty T, Milligan P, Jaye A, Tornieporth N, Ballou R, McAdam KP, Cohen J, Hill AV.   Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia. Clin Exp Immunol. 2004 Feb;135(2):286-93.

9983.   Satayavivad J, Watcharasit P, Khamkong P, Tuntawiroon J, Pavaro C, Ruchirawat S.  The pharmacodynamic study of a potent new antimalarial (MC1). Acta Trop. 2004 Feb;89(3):343-9.